SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-23-002542
Filing Date
2023-04-20
Accepted
2023-04-20 14:53:29
Documents
22
Period of Report
2023-04-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT phio_8k.htm   iXBRL 8-K 41072
2 FORM OF SERIES A COMMON STOCK WARRANT phio_ex0401.htm EX-4.1 124978
3 FORM OF SERIES B COMMON STOCK WARRANT phio_ex0402.htm EX-4.2 124978
4 FORM OF EXISTING WARRANT AMENDMENT phio_ex0403.htm EX-4.3 12942
5 OPINION AND CONSENT OF HOGAN LOVELLS US LLP phio_ex0501.htm EX-5.1 18114
6 SECURITIES PURCHASE AGREEMENT phio_ex1001.htm EX-10.1 267563
7 PRESS RELEASE phio_ex9901.htm EX-99.1 14061
8 PRESS RELEASE phio_ex9902.htm EX-99.2 13797
12 GRAPHIC image_001.jpg GRAPHIC 2231
13 GRAPHIC image_002.jpg GRAPHIC 3115
14 GRAPHIC image_003.jpg GRAPHIC 2555
  Complete submission text file 0001683168-23-002542.txt   939524

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE phio-20230418.xsd EX-101.SCH 2965
10 XBRL LABEL FILE phio-20230418_lab.xml EX-101.LAB 34240
11 XBRL PRESENTATION FILE phio-20230418_pre.xml EX-101.PRE 22363
16 EXTRACTED XBRL INSTANCE DOCUMENT phio_8k_htm.xml XML 3614
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36304 | Film No.: 23832727
SIC: 2834 Pharmaceutical Preparations